CG1:LSE:LSE-Amundi ETF DAX UCITS ETF DR (GBX)

ETF | Others |

Last Closing

USD 27232.5

Change

+125.00 (+0.46)%

Market Cap

USD 0.65B

Volume

458.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.30 (+0.11%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

-0.63 (-0.93%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.06 (+3.40%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.16 (+1.16%)

USD 553.83B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.18 (+1.07%)

USD 553.83B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+15.00 (+0.76%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

-0.10 (-0.16%)

USD 266.08B
0QZO:LSE 0QZO

-0.50 (-0.49%)

USD 258.54B

ETFs Containing CG1:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.41% 55% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.41% 55% F 57% F
Trailing 12 Months  
Capital Gain 9.84% 59% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.84% 58% F 61% D-
Trailing 5 Years  
Capital Gain 35.99% 60% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.99% 57% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.24% 63% D 67% D+
Dividend Return 8.24% 62% D 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.36% 51% F 66% D+
Risk Adjusted Return 57.35% 69% C- 81% B-
Market Capitalization 0.65B 73% C 56% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike